Volume 12, Issue 4 (10-2024)                   J. Pediatr. Rev 2024, 12(4): 369-376 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Noorian S, Moravej H, Afshar Z, Hassanzadeh Rad A, Dalili S. Glycogen Storage Disease Type IX in a 6-year-old Male: A Case Report. J. Pediatr. Rev 2024; 12 (4) :369-376
URL: http://jpr.mazums.ac.ir/article-1-676-en.html
1- Department of Pediatrics, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
2- Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
3- Department of Pediatric Endocrinology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
4- Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
5- Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran. , setiladalili1346@yahoo.com
Abstract:   (822 Views)
Background: Glycogen storage diseases (GSDs) are a group of inherited metabolic disorders caused by enzyme deficiencies affecting glycogen synthesis or breakdown. Glycogen, stored mainly in the liver and muscles, is crucial for maintaining glucose levels during fasting or physical activity. GSDs lead to abnormal glycogen accumulation or impaired mobilization, causing symptoms, such as hypoglycemia, hepatomegaly, and muscle weakness. Each type of GSD results from a specific enzyme deficiency, requiring tailored management. 
Case Presentations: A case study of a 6-year-old boy with GSD type IX is presented, highlighting recurrent hypoglycemia, growth delay, and elevated liver enzymes. Genetic testing confirmed a PHKA2 mutation, and the patient’s management included frequent meals, cornstarch therapy, and regular liver function monitoring. The discussion emphasizes the importance of early diagnosis, genetic testing, and personalized treatment in managing GSDs. 
Conclusions: Future therapies, such as gene therapy and enzyme replacement, aim to address the root causes of GSDs rather than merely managing symptoms. Family education on hypoglycemia recognition and dietary restrictions is crucial for improving patient outcomes. Ongoing research into the molecular mechanisms of GSDs offers hope for more effective treatments, especially for GSD type IX, where individualized care can prevent complications like liver cirrhosis and promote better quality of life.
Full-Text [PDF 384 kb]   (382 Downloads) |   |   Full-Text (HTML)  (642 Views)  
Type of Study: Narrative Review | Subject: Endocrinology
Received: 2024/05/12 | Accepted: 2024/06/28 | Published: 2024/10/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Pediatrics Review

Designed & Developed by : Yektaweb